Adaptive approach to trial design and operation is key, Health Decisions

By Gareth Macdonald

- Last updated on GMT

Related tags Clinical trial

Adaptive approach to trial design and operation is key, Health Decisions
An adaptive approach to both the design and operation of a clinical trial can boost efficiency, reduce timelines and cut costs says Health Decisions' CEO Michael Rosenberg.

Rosenberg spoke with Outsourcing-pharma at DIA Euro Meeting in Monaco and explained that although adaptive clinical trial design is a well established practice, CROs and drugmakers have only "scraped the surface​" in the use of an adaptive approach to trial operations.

He highlighted enrollment as one operational area that could be improved explaining that Health Decisions' research indicates that 76 per cent of adaptive trials meet enrollment timelines compared with just 15 per cent of traditional studies.

The other advantage of an adaptive approach to trial operations is that, unlike adaptive changes at the design level, they do not require regulatory approval and thus give CROs and sponsors direct control over some of the most costly and time consuming aspects of a clinical study.

Related news

Show more

Related products

show more

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us

Products

View more

Webinars